ATR and acute lymphoblastic leukemia: Overall, our findings suggest that nucleotide biosynthetic plasticity in lymphoblastic leukemia cells, and potentially in other malignancies, is mediated by both ATR signaling and nucleotide metabolic adaptive mechanisms which may be targetable without overt toxicity to normal tissues, using existing small molecule inhibitors.